01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#POLB Poolbeg Pharma PLC – Interim Results for the six months to 30 June 2025 September 29, 2025 – Posted in: Poolbeg Pharma (POLB)

  29 September 2025 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces its unaudited interim results for the six months to 30 June 2025. Highlights & Updates • Cash balance of £10.0 million as at 30 June 2025, including £4.865 million gross proceeds raised as part of an oversubscribed and upsized fundraise • Cash runway extended into 2027, supporting the delivery of multiple…

Continue reading

#POLB Poolbeg Pharma PLC – POLB 001 Phase 2a Trial Update September 25, 2025 – Posted in: Poolbeg Pharma (POLB)

25 September 2025 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces that the Company has signed an agreement for a specialist blood cancer trials organisation, Accelerating Clinical Trials Limited (“ACT”), to conduct the upcoming POLB 001 Phase 2a trial and has also secured the supply of an approved bispecific antibody drug for the trial at no cost to the Company. The…

Continue reading

Alpha Prospects – MSAART Chimney Technology Licence – India March 13, 2024 – Posted in: Alpha Prospects Ltd, Blog

“This technology provides unprecedented reduction in harmful emissions whilst simultaneously increasing oxygen levels from near zero to normal atmospheric levels in coal and wood burning power plants.” Alpha Prospects Ltd, the investment management company focussed on innovative energy solutions, is pleased to announce that it has entered into an agreement with Strike Foundation Guarantee Limited, (STRIKE Foundation”); Strategic Technology Resources Industry Knowledge and Empowerment (STRIKE) and Strike Ground Zero Ltd (SGZ) to license the intellectual…

Continue reading